A one-day conference bringing lawyers, judges, and scholars together to discuss emerging legal issues in biotech patent law. Panel discussions will include: licensing; enablement and written description requirements; nonobviousness and the inherency doctrine; gene patents and policy; and trying biotech patent cases. The keynote address will be delivered by John H. Barton, Stanford's George E. Osborne Professor of Law, Emeritus.